Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOWGet Free Report) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 43,800 shares, an increase of 6.8% from the February 29th total of 41,000 shares. Based on an average daily trading volume, of 15,500 shares, the short-interest ratio is presently 2.8 days.

Cardio Diagnostics Trading Up 21.4 %

Shares of CDIOW traded up $0.01 on Wednesday, reaching $0.08. 13,251 shares of the company’s stock were exchanged, compared to its average volume of 17,783. The business has a 50 day moving average price of $0.13 and a two-hundred day moving average price of $0.11. Cardio Diagnostics has a 12 month low of $0.03 and a 12 month high of $0.37.

About Cardio Diagnostics

(Get Free Report)

Cardio Diagnostics Holdings, Inc, an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.

Featured Stories

Receive News & Ratings for Cardio Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardio Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.